Stockreport

PhaseBio Expands Executive Management Team

PhaseBio Pharmaceuticals, Inc.  (PHAS) 
Last phasebio pharmaceuticals, inc. earnings: 3/30 08:01 am Check Earnings Report
PDF MALVERN, Pa. and SAN DIEGO, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused [Read more]